Search research articles
Contact Us
Filters
Showing results (321-330 of 527) with videos related to
Page
of 53
Sort By:
Blood
|
August 4, 2012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
Felix Sahm, David Capper, Matthias Preusser, et al.
Brain Pathology (Zurich, Switzerland)
|
December 19, 2013
BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression
Christian Koelsche, Felix Sahm, Adelheid Wöhrer, et al.
Journal of Neuro-Oncology
|
April 29, 2020
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
Maximilian J Mair, Adelheid Wöhrer, Julia Furtner, et al.
Journal of Neuro-Oncology
|
July 16, 2018
Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
Julia Furtner, Anna S Berghoff, Veronika Schöpf, et al.
Histopathology
|
February 17, 2012
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Matthias Preusser, Romana Hoeftberger, Adelheid Woehrer, et al.
Acta Neuropathologica
|
August 8, 2024
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma
Sybren L N Maas, Thomas Hielscher, Philipp Sievers, et al.
Blood
|
January 12, 2017
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
Julia Riedl, Matthias Preusser, Pegah Mir Seyed Nazari, et al.
ESMO Open
|
November 13, 2020
Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours
Maximilian J Mair, Sahra Pajenda, Aysegül Ilhan-Mutlu, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2022
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
Angelika Martina Starzer, Gerwin Heller, Erwin Tomasich, et al.
Neuro-Oncology
|
September 19, 2025
EANS-EANO Guidelines on the extent of resection in gliomas
Roland Goldbrunner, Nicolas Foroglou, Francesco Signorelli, et al.
Page
of 53
Search research articles
Search
Showing results (321-330 of 527) with videos related to
Sort By:
Page
of 53
Blood
|
August 4, 2012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
Felix Sahm, David Capper, Matthias Preusser, et al.
Brain Pathology (Zurich, Switzerland)
|
December 19, 2013
BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression
Christian Koelsche, Felix Sahm, Adelheid Wöhrer, et al.
Journal of Neuro-Oncology
|
April 29, 2020
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
Maximilian J Mair, Adelheid Wöhrer, Julia Furtner, et al.
Journal of Neuro-Oncology
|
July 16, 2018
Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
Julia Furtner, Anna S Berghoff, Veronika Schöpf, et al.
Histopathology
|
February 17, 2012
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Matthias Preusser, Romana Hoeftberger, Adelheid Woehrer, et al.
Acta Neuropathologica
|
August 8, 2024
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma
Sybren L N Maas, Thomas Hielscher, Philipp Sievers, et al.
Blood
|
January 12, 2017
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
Julia Riedl, Matthias Preusser, Pegah Mir Seyed Nazari, et al.
ESMO Open
|
November 13, 2020
Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours
Maximilian J Mair, Sahra Pajenda, Aysegül Ilhan-Mutlu, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2022
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
Angelika Martina Starzer, Gerwin Heller, Erwin Tomasich, et al.
Neuro-Oncology
|
September 19, 2025
EANS-EANO Guidelines on the extent of resection in gliomas
Roland Goldbrunner, Nicolas Foroglou, Francesco Signorelli, et al.
Page
of 53